Biology Reference
In-Depth Information
Sotiropoulos A, Groner B, Gouilleux F (1996) Deletion of the carboxyl-terminal transactivation
domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol
Cell Biol 16: 5691-5700
120 Verdier F, Walrafen P, Hubert N, Chretien S, Gisselbrecht S, Lacombe C, Mayeux P (2000)
Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-reg-
ulation of cell surface receptors. J Biol Chem 275: 18375-18381
121 Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura
S, Ohtsubo M, Misawa H et al. (1997) A new protein containing an SH2 domain that inhibits JAK
kinases. Nature 387: 921-924
122 Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi
T, Matsuda T, Ihle JN et al. (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase
activity through binding in the activation loop. EMBO J 18: 1309-1320
123 Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga
T,Yoshizaki K et al. (1997) Structure and function of a new STAT-induced STAT inhibitor.
Nature 387: 924-929
124 Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL,
Darwiche R, Owczarek CM et al. (1999) SOCS1 is a critical inhibitor of interferon gamma sig-
naling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608
125 Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura K (1994) Chronic
active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci
USA 91: 614-618
126 Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA,
Yoshimura A (1999) Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine
kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes
Cells 4: 339-351
127 Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa
H, Sasaki A, Yoshimura A et al. (1999) SOCS3 is essential in the regulation of fetal liver ery-
thropoiesis. Cell 98: 617-627
128 Wojchowski DM, Gregory RC, Miller CP, Pandit AK, Pircher TJ (1999) Signal transduction in
the erythropoietin receptor system. Exp. Cell Res 253: 143-156
129 Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF (1995) Specific recruitment of SH-
PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative
signals. Cell 80:729-738
130 Sharlow ER, Pacifici R, Crouse J, Batac J, Todokoro K, Wojchowski DM (1997) Hematopoietic
cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in ery-
throleukemic SKT6 cells. Blood 90: 2175-2187
131 Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR (1993)
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phos-
phatase (Hcph) gene. Cell 73: 1445-1454
132 Tsui HW, Siminovitch KA, de Souza L, Tsui FW (1993) Motheaten and viable motheaten mice
have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4: 124-129
133 Bignon JS, Siminovitch KA (1994) Identification of PTP1C mutation as the genetic defect in
motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phos-
phatases in the regulation of hemopoietic cell differentiation and function. Clin Immunol
Immunopathol 73: 168-179
134 de la Chapelle A, Sistonen P, Lehvaslaiho H, Ikkala E, Juvonen E (1993) Familial erythrocytosis
genetically linked to erythropoietin receptor gene. Lancet 341: 82-84
135 de la Chapelle A, Traskelin AL, Juvonen E (1993) Truncated erythropoietin receptor causes dom-
inantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90: 4495-4499
136 Watowich SS, Xie X, Klingmuller U, Kere J, Lindlof M, Berglund S, de la Chapelle A (1999)
Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity
to erythropoietin in the heterozygous state. Blood 94: 2530-2532
137 Sokol L, Prchal JF, D'Andrea A, Rado TA, Prchal JT (1994) Mutation in the negative regulatory
element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Exp
Hematol 22: 447-453
138 Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT (1995) Primary familial poly-
cythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of
erythroid progenitors to erythropoietin. Blood 86: 15-22
Search WWH ::




Custom Search